BP
Boobalan Pachaiyappan Roth Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
16
Avg Return
Past Year
Past Year
78%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $3 |
40%
upside
| 1 | +32% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $16 |
134%
upside
| 3 | +31% |
0
%
| 19 Nov ‘25 3 months ago |
|
|
|
Buy
Maintained
| $9 |
115%
upside
| 3 | +12% |
0
%
| 13 Nov ‘25 3 months ago |
|
|
|
Buy
Maintained
| $13 |
58%
downside
| 3 | +112% |
0
%
| 12 Nov ‘25 3 months ago |
|
|
|
Buy
Initiated
| $62 | – | 1 | +76% |
0
%
| 17 Sep ‘25 5 months ago |
|
|
|
Buy
Reiterated
| $3 |
4%
upside
| 1 | +433% |
0
%
| 18 Aug ‘25 6 months ago |
|
|
|
Buy
Maintained
| $3 |
467%
upside
| 1 | -30% |
0
%
| 15 Aug ‘25 6 months ago |
|
|
|
Buy
Maintained
| $6 |
105%
upside
| 1 | +92% |
0
%
| 13 Aug ‘25 6 months ago |
|
|
|
Buy
Reiterated
| $16 |
252%
upside
| 3 | +87% |
0
%
| 12 Aug ‘25 6 months ago |
|
|
|
Buy
Reiterated
| $116 | – | 1 | +15% |
0
%
| 18 Jun ‘25 8 months ago |
|